PARIS (Reuters)

H1N1 flu virus,

Čini mi se daje ovo bas vijest koja nam govori o dilemi da li je bilo dobro primiti vakcinu ili ne.Ono što se u ovom slučaju valjalo iza brda je konstatacija napisana pri dnu teksta

LONDON/PARIS, Jan 5 (Reuters) - France's decision to cancel over half the swine flu vaccines it ordered has increased concerns that manufacturers' revenues from the H1N1 pandemic will be lower than forecast.

Move follows cutbacks by Germany, Spain and Switzerland
* Shares in vaccine makers Glaxo, Sanofi, Novartis slide

The Health Ministry said it had originally bought the 94 mil. vaccines at a cost of 869 million euros. Bachelot said the canceled order would save more than 350 million euros.

Opposition politicians have criticized the government, saying it has wasted money and helped drugs companies. Socialist Party spokesman Benoit Hamon said large pharmaceutical firms were „the big winners in this affair.”